In 2010, Graesslin et al. published a nomogram to predict the chance of developing brain metastasis in female BC patients, but the presence of germline PV in BRCA1/2 was not included in the variables evaluated. The gene discussed is BRCA1; the disease is acquired polycythemia vera.